Folger Nolan Fleming Douglas Capital Management, Inc
Source: SEC Form 13F · as of Mar 2026Folger Nolan Fleming Douglas Capital Management, Inc holds 12 biotech & pharma companies tracked by BioSniper, totaling $71.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$71.2M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 104,039 | $25.4M |
| MRKMerck & Co., Inc. | 128,401 | $15.4M |
| ABTABBOTT LABORATORIES | 103,015 | $10.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 30,121 | $8.2M |
| LLYELI LILLY & Co | 4,838 | $4.4M |
| ABBVAbbVie Inc. | 13,867 | $3.0M |
| AMGNAMGEN INC | 4,954 | $1.7M |
| BMYBRISTOL MYERS SQUIBB CO | 10,194 | $618K |
| PMPhilip Morris International Inc | 3,625 | $599K |
| PFEPFIZER INC | 15,790 | $443K |
| GEHCGE HealthCare Technologies Inc. | 5,124 | $365K |
| ZBHZimmer Biomet Holdings Inc. | 3,936 | $356K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.